(Press-News.org) TUCSON, Ariz., March 25, 2024 — Critical Path Institute (C-Path) today announced the formation of a new task force under its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), dedicated to advancing therapeutic development for Progressive Supranuclear Palsy (PSP). This initiative brings together leading organizations and experts in a concerted effort to tackle the challenges associated with PSP drug development. PSP is a brain disorder that affects movement, control of walking and balance, speech, swallowing, vision, mood, behavior and thought.
The confirmed members of the task force include the Rainwater Charitable Foundation, CurePSP, The Association for Frontotemporal Degeneration (AFTD), Novartis, and Dr. Adam Boxer, a distinguished neurologist at the UCSF Memory and Aging Center.
This task force aims to leverage the collective expertise of its members to foster innovation and expedite the development of new treatments for PSP. By integrating patient-level data from diverse sources through RDCA-DAP, the task force will work to identify and address the critical gaps in PSP research and development. The collaboration provides a neutral platform for stakeholders from industry, regulatory agencies, academia, and the PSP community to engage in meaningful dialogue and share data, enhancing the efficiency of therapeutic advancements for PSP.
“Progressive Supranuclear Palsy is a devastating condition with significant unmet medical needs,” said Alexandre Betourne, Pharm. D., Ph.D., RDCA-DAP Executive Director and lead for this effort. “By convening this task force, we are harnessing the collective strengths and knowledge of our members to drive forward the development of effective treatments for those affected by PSP.”
The task force’s approach is rooted in C-Path’s proven track record of fostering collaboration and accelerating drug development processes. Its focus will include establishing data management standards, identifying biomarkers, and utilizing modeling and analytics to inform regulatory science and clinical outcome assessments. This strategic effort is designed to de-risk the decision-making process in drug development and enhance the regulatory review of novel therapeutics for PSP.
“As the leading nonprofit organization serving those living with Progressive Supranuclear Palsy, we’re thrilled to be part of this enabling initiative,” said Kristophe Diaz, Ph.D., Executive Director, and Chief Science Officer at CurePSP. “Data sharing, data access, and public-private partnerships are needed to make a difference. We’re committed to supporting this endeavor and to representing the patient voice in partnership with C-Path.”
For further information and to inquire about joining the RDCA-DAP Task Force on Progressive Supranuclear Palsy, interested parties are encouraged to contact rdca-dapadmin@c-path.org.
About Critical Path Institute
Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org.
Critical Path Institute is supported by the Food and Drug Administration (FDA) of the Department of Health and Human Services (HHS) and is 54% funded by the FDA/HHS, totaling $19,436,549, and 46% funded by non-government source(s), totaling $16,373,368. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. Government.
About RDCA-DAP
The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP ®), a joint initiative by C-Path and NORD with support from FDA, offers a unique platform promoting cooperation among various stakeholders, including academic institutions, industry leaders, healthcare organizations, and patient advocacy groups. It accelerates the development of treatments for rare diseases through data sharing, analysis, and collaboration. For more information, visit c-path.org/rdca-dap.
END
C-Path to spearhead new task force dedicated to accelerating drug development for progressive supranuclear palsy
2024-03-25
ELSE PRESS RELEASES FROM THIS DATE:
SFU professor leads global roadmap to advance printable sensors for sustainability and quality of lif
2024-03-25
A Simon Fraser University professor is helping make strides towards a “sustainable, intelligent world” by propelling printable sensor technologies.
Vincenzo Pecunia, from SFU’s School of Sustainable Energy Engineering, led a team of more than 100 experts from 57 research institutions worldwide in developing a comprehensive roadmap for next-generation printable sensor technologies. By paving the way for everyday objects and environments to acquire sensing capabilities, these technologies could be a game changer in advancing sustainability and enhancing our quality ...
ORNL helping Roll-to-Roll Consortium scale up hydrogen technology
2024-03-25
The Department of Energy’s Oak Ridge National Laboratory is providing national leadership in a new collaboration among five national laboratories to accelerate U.S. production of clean hydrogen fuel cells and electrolyzers.
Hydrogen fuel cells provide power to electric vehicles and buildings using an electrochemical reaction that converts hydrogen and oxygen into heat, water and electricity. The Roll-to-Roll, or R2R, Consortium aims to scale up, speed up and reduce the cost of producing key components ...
Research news from the Ecological Society of America’s journals
2024-03-25
The Ecological Society of America (ESA) presents a roundup of five research articles recently published across its six esteemed journals. Widely recognized for fostering innovation and advancing ecological knowledge, ESA’s journals consistently feature innovative and impactful studies. This compilation of papers explores invasive possum management in New Zealand, afforestation on global rangelands, population regulation in large herbivores and more, showcasing the Society’s commitment to promoting cutting-edge research that furthers ...
ASU Regents Professor inducted into 2024 class of AIMBE College of Fellows
2024-03-25
The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Regents Professor Petra Fromme, director of the Biodesign Center for Applied Structural Discovery at Arizona State University, to its College of Fellows.
Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, an honor reserved only for the top 2% of researchers in these fields.
"We welcome Petra's well-earned induction into ...
Novel electrochemical sensor detects dangerous bacteria
2024-03-25
Each year, bacterial infections claim several million lives worldwide. That is why detecting harmful microorganisms is crucial – not only in the diagnosis of diseases but also, for example, in food production. However, the methods available so far are often time-consuming, require expensive equipment or can only be used by specialists. Moreover, they are often unable to distinguish between active bacteria and their decay products.
By contrast, the newly developed method detects only intact bacteria. It makes use of the fact that ...
Cancer therapies show promise in combating tuberculosis
2024-03-25
EMBARGOED UNTIL MARCH 25, 2024 AT 3:00 PM US EST
What could cancer teach us about tuberculosis? That’s a question Meenal Datta has been chasing since she was a graduate student.
Once the body’s immune system is infected with tuberculosis, it forms granulomas — tight clusters of white blood cells — in an attempt to wall off the infection-causing bacteria in the lungs. But more often than not, granulomas do more harm than good.
Charged with analyzing the similarities between granulomas and tumors, Datta discovered that both are structurally and functionally abnormal. ...
Gotta go? New bladder device lets you know
2024-03-25
Should you run to the bathroom now? Or can you hold it until you get home? A new implant and associated smartphone app may someday remove the guess work from the equation.
Northwestern University researchers have developed a new soft, flexible, battery-free implant that attaches to the bladder wall to sense filling. Then, it wirelessly — and simultaneously — transmits data to a smartphone app, so users can monitor their bladder fullness in real time.
The study will be published next week in the Proceedings of the National Academy of Sciences (PNAS). It ...
Seeing the forest for the trees: Species diversity is directly correlated with productivity in eastern U.S. forests
2024-03-25
When scientists and policymakers make tough calls on which areas to prioritize for conservation, biodiversity is often their top consideration. Environments with more diversity support a greater number of species and provide more ecosystem services, making them the obvious choice.
There’s just one problem. There are several ways to measure diversity, and each reveals a slightly different, and sometimes conflicting, view of how life interacts in a forest or other ecosystem.
In a new study published ...
Pairing crypto mining with green hydrogen offers clean energy boost
2024-03-25
ITHACA, N.Y. – Pairing cryptocurrency mining – notable for its outsize consumption of carbon-based fuel – with green hydrogen could provide the foundation for wider deployment of renewable energy, such as solar and wind power, according to a new Cornell University study.
“Since current cryptocurrency operations now contribute heavily to worldwide carbon emissions, it becomes vital to explore opportunities for harnessing the widespread enthusiasm for cryptocurrency as we move toward a sustainable and a climate-friendly future,” said Fengqi You, professor of energy systems engineering at Cornell.
You and doctoral ...
With a new experimental technique, MIT engineers probe the mechanisms of landslides and earthquakes
2024-03-25
Granular materials, those made up of individual pieces, whether grains of sand or coffee beans or pebbles, are the most abundant form of solid matter on Earth. The way these materials move and react to external forces can determine when landslides or earthquakes happen, as well as more mundane events such as how cereal gets clogged coming out of the box. Yet, analyzing the way these flow events take place and what determines their outcomes has been a real challenge, and most research has been confined to two-dimensional experiments that don’t ...